Abstract
Policy and Economic Considerations for the Provision of Global Public Goods: Biomedical Research and Development
Highlights
The concept of global public goods represents a framework for organizing and financing international cooperation in global health research and development (R&D)
Advances in scientific and clinical knowledge produced by biomedical R&D can be considered public goods insofar as they can be used repeatedly and it is difficult or costly to exclude non-payers from gaining access
This paper considers the public good characteristics of biomedical R&D in global health and describes the theoretical and observed factors in the allocation R&D funding by public, private, and philanthropic sources
Summary
The concept of global public goods represents a framework for organizing and financing international cooperation in global health research and development (R&D). Outcome & Evaluation: The partnership assessment process has allowed the USAMC to develop strategic, long-term, institutional relationships based on similar approach and goals in countries of operation and to disengage from potential partnerships that bring excessive risk and minimal value add. Policy and Economic Considerations for the Provision of Global Public Goods: Biomedical Research and Development
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
